Asia-Pacific Airway Management Device Market Outlook to 2028

Asia-Pacific Airway Management Device Market Overview

The Asia-Pacific airway management device market is valued at USD 1.95 billion based on a five-year historical analysis. This market is driven by the rising incidence of respiratory diseases, increased surgical procedures, and growing awareness about advanced airway management techniques. The increasing prevalence of chronic obstructive pulmonary disease (COPD) and asthma across major countries in the region has led to a high demand for airway management devices.

Dominant countries such as China, Japan, and India lead the airway management device market in the Asia-Pacific region. The dominance of these countries is attributed to their large populations, well-established healthcare infrastructure, and increasing healthcare expenditure. Additionally, China and Japans significant investments in medical technology and innovation further consolidate their leading positions in the market.

Medical device reporting systems have become a key focus for healthcare regulators in the region. In 2023, China updated its Medical Device Adverse Event Reporting system, requiring more detailed post-market surveillance. Compliance rates among medical device manufacturers reached 85% that year, reflecting the increased pressure to monitor and report device performance, especially for airway management tools.

Asia-Pacific Airway Management Device Market Segmentation

By Device Type: The Asia-Pacific airway management device market is segmented by device type into endotracheal tubes, tracheostomy tubes, supraglottic airway devices, nasopharyngeal airways, and oropharyngeal airways. Endotracheal tubes hold a dominant market share due to their frequent use in surgeries and emergency situations. This sub-segment's dominance is driven by the increasing number of surgeries, the growing adoption of ventilators, and their critical role in airway management during anesthesia and critical care. Additionally, the development of single-use and disposable endotracheal tubes has boosted demand, especially in infection-control-sensitive environments like hospitals and clinics.

By End User: The Asia-Pacific airway management device market is segmented by end user into hospitals, ambulatory surgical centers (ASCs), clinics, and homecare settings. Hospitals dominate this segment, with a substantial share of airway management devices being used in hospital settings due to the high volume of surgeries, emergency treatments, and respiratory care provided. Hospitals are the primary users of advanced airway devices because they offer a broader range of services that require specialized equipment, from routine surgeries to critical care for severe respiratory disorders.

Asia-Pacific Airway Management Device Market Competitive Landscape

The Asia-Pacific airway management device market is characterized by the presence of several key players. The market is dominated by large global medical device companies and regional players that have developed a strong foothold due to innovation and strategic partnerships. These companies invest heavily in research and development to introduce new and innovative products, which helps them stay competitive in the market.

Company

Establishment Year

Headquarters

R&D Spending

Global Reach

Product Portfolio

Patents

Market Share

No. of Employees

Teleflex Inc.

1943

Wayne, Pennsylvania

Medtronic PLC

1949

Dublin, Ireland

Ambu A/S

1937

Copenhagen, Denmark

Fisher & Paykel Healthcare

1934

Auckland, New Zealand

Smiths Medical

1940

London, United Kingdom

Asia-Pacific Airway Management Device Industry Analysis

Growth Drivers

Increasing Prevalence of Chronic Respiratory Diseases: The Asia-Pacific region has seen a significant rise in chronic respiratory diseases such as asthma, COPD, and bronchitis, particularly in countries like China and India. By 2020, it was estimated that the East Asia and Pacific region had around 136 million cases of COPD, with projections indicating significant increases by 2050. This rise in patient demographics has increased the demand for airway management devices in hospital settings across the region.

Aging Population: The aging population across Asia-Pacific has also driven the demand for airway management devices, as older adults are more prone to respiratory complications. Japan's elderly population ratio is reported as 29.1% of its total population, with approximately 36.2 million individuals aged 65 or older as of September 2023. This surge is mirrored across countries like South Korea, China, and Australia. A higher geriatric population results in greater hospital admissions for surgeries and respiratory issues, driving airway management demand. The increased demand for geriatric care is expected to further stretch healthcare resources in the region.

Increasing Surgical Procedures: The growing number of surgeries in Asia-Pacific, particularly in countries like Australia, South Korea, and China, has significantly increased the demand for airway management devices. With a rise in both elective and emergency procedures, healthcare facilities are relying more on advanced airway devices to ensure patient safety and operational efficiency during surgeries, driving the need for effective airway management solutions across the region.

Market Challenges

High Cost of Devices: The high cost of airway management devices presents a significant barrier in the Asia-Pacific region, especially in low- and middle-income countries. Advanced devices are often expensive, making them less accessible in countries with lower healthcare spending. This price disparity between developed and emerging markets limits the widespread adoption of advanced technologies, as healthcare providers in lower-income regions struggle to afford and integrate these devices into their systems.

Stringent Regulatory Requirements: The regulatory landscape for medical devices in Asia-Pacific varies by country, often making market entry challenging. Strict regulations can lead to longer approval times, especially for advanced medical devices. Companies looking to expand into the region must navigate complex compliance requirements, which can slow down product launches. This regulatory variability complicates market access and increases the cost and time associated with introducing new airway management devices.

Asia-Pacific Airway Management Device Market Future Outlook

Over the next five years, the Asia-Pacific airway management device market is expected to grow significantly. The markets growth will be driven by continuous technological advancements, increasing awareness about respiratory health, and growing government support to improve healthcare access. The rising elderly population in the region will also contribute to the increased demand for airway management devices, especially in critical care settings.

Market Opportunities

Expanding Medical Tourism: Medical tourism is rapidly growing in Asia-Pacific, with countries like Thailand, Singapore, and India attracting a large number of international patients seeking cost-effective, high-quality healthcare. This surge in medical tourism has boosted the demand for advanced airway management devices, particularly in surgical centers that cater to these patients. As more tourists seek medical procedures, the need for modern medical devices presents significant opportunities for market expansion in the region.

Untapped Markets in Emerging Economies: Emerging economies in Asia-Pacific, such as Vietnam, the Philippines, and Indonesia, offer promising opportunities for the airway management device market. These nations are progressively investing in healthcare infrastructure, aiming to improve access to advanced medical technologies. As healthcare systems in these countries expand, there is a growing potential for the adoption of airway management devices, opening up new market prospects.
Please Note: It will take 5-7 business days to complete the report upon order confirmation